David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
BJ's Restaurants
BJRI
$1.42B
| $2.61M | ﹤0.01% |
85,633
+71,424
| +503% | +$2.31M |
|
1802
Shutterstock
SSTK
$205M
| $2.6M | ﹤0.01% |
78,223
-3,125
| -4% | -$115K |
|
1803
The Bancorp
TBBK
$2.7B
| $2.6M | ﹤0.01% |
314,762
+93,691
| +42% | +$726K |
|
|
POT
1804
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $2.6M | ﹤0.01% |
135,300
| – | – |
|
1805
CALL
Ubiquiti
UI
$36.1B
| $2.59M | ﹤0.01% |
46,300
| – | – |
|
1806
Wipro
WIT
$18.1B
| $2.59M | ﹤0.01% |
+1,216,800
| New | +$2.67M |
|
1807
ePlus
PLUS
$2.25B
| $2.59M | ﹤0.01% |
55,952
-13,454
| -19% | -$549K |
|
|
LHO
1808
DELISTED
LaSalle Hotel Properties
LHO
| $2.58M | ﹤0.01% |
88,742
-71,219
| -45% | -$2.06M |
|
1809
Adtran
ADTN
$645M
| $2.57M | ﹤0.01% |
107,162
-18,771
| -15% | -$415K |
|
|
BIVV
1810
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $2.57M | ﹤0.01% |
45,050
| – | – |
|
|
GSS
1811
DELISTED
Golden Star Resources Ltd.
GSS
| $2.57M | ﹤0.01% |
668,729
+30,631
| +5% | +$108K |
|
1812
Bio-Rad Laboratories Class A
BIO
$10.4B
| $2.56M | ﹤0.01% |
11,536
-1,400
| -11% | -$315K |
|
|
RPT
1813
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.56M | ﹤0.01% |
196,868
-203,049
| -51% | -$2.72M |
|
1814
Tilly's
TLYS
$120M
| $2.56M | ﹤0.01% |
213,531
-5,901
| -3% | -$61.5K |
|
|
CSLT
1815
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.55M | ﹤0.01% |
593,411
+6,571
| +1% | +$27.1K |
|
|
CMRX
1816
DELISTED
Chimerix, Inc.
CMRX
| $2.55M | ﹤0.01% |
485,664
-21,635
| -4% | -$106K |
|
|
FLXN
1817
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.55M | ﹤0.01% |
105,458
+69,401
| +192% | +$1.63M |
|
|
BWLD
1818
CALL
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $2.55M | ﹤0.01% |
24,100
+8,000
| +50% | +$890K |
|
1819
PUT
Howmet Aerospace
HWM
$107B
| $2.54M | ﹤0.01% |
133,399
| – | – |
|
|
MDR
1820
DELISTED
McDermott International
MDR
| $2.54M | ﹤0.01% |
116,586
-118,370
| -50% | -$2.37M |
|
1821
CALL
Essex Property Trust
ESS
$18.5B
| $2.54M | ﹤0.01% |
10,000
| – | – |
|
|
AAMI
1822
Acadian Asset Management
AAMI
$3.39B
| $2.53M | ﹤0.01% |
169,604
-102,819
| -38% | -$1.47M |
|
|
HIMX
1823
Himax Technologies
HIMX
$2.41B
| $2.52M | ﹤0.01% |
230,666
+143,768
| +165% | +$1.31M |
|
|
MTSC
1824
DELISTED
MTS Systems Corp
MTSC
| $2.52M | ﹤0.01% |
47,102
+1,458
| +3% | +$73.5K |
|
|
HDP
1825
DELISTED
Hortonworks, Inc.
HDP
| $2.52M | ﹤0.01% |
148,372
-994
| -0.7% | -$15K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.